JPRN-UMIN000025278
Completed
未知
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations. - An observational study of plasma EGFR mutation status during osimertinib treatment.
Conditionslung Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- lung Cancer
- Sponsor
- Miyagi Cancer Center
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Having an evidence of ILD or pulmonary fibrosis complication on chest X\-ray. 2\. Having a history or serious complications as bellows: 1\) uncontrollable angina pectoris, cardial infarction within 3 months before enrollment, or heart failure. 2\) uncontrollable diabetes or hypertension. 3\) Severe infectious disease.. 4\) gastrointestinal dysfunction with severe diarrhea. 3\. Impossible to take drugs orally. 4\. Inadequate case considered from drug package insert of osimertinib.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An obsevational study of EGFR mutation status by circulating tumor DNA and tissue during the osimertinib treatment in poor PS patients with T790M positive advanced NSCLCnon small cell lung cancerJPRN-UMIN000025718orth East Japan Study Group (NEJSG)32
Completed
Not Applicable
Prospective observational study of EGFR mutation allele frequency using Cell free DNAJPRN-UMIN000036149Hamamatsu University School of Medicine33
Recruiting
Not Applicable
The continuous evaluation of EGFR mutation in EGFR-mutation positive lung cancer patients during EGFR TKI treatmentnon-small cell lung cancerJPRN-UMIN000037232Advanced Cancer Translational Research Institute100
Completed
Not Applicable
The analysis of significance of EGFR mutations in lung non-adeno and non small cell carcinoma; retrospective multicenter studyEGFR mutations in lung non-adeno and non small cell carcinomaJPRN-UMIN000007294ung Oncology Group in Kyushu, Japan (LOGIK)100
Completed
Not Applicable
Exploratory study of detection of mutated EGFR from plasma of patients with EGFR mutant non-small cell lung cancer resistant to EGFR-TKI.JPRN-UMIN000007817Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital26